Yes, it is common for people with Primary Biliary Cholangitis (PBC) to be prescribed both Ursodeoxycholic Acid (UDCA) and Ocaliva (Obeticholic Acid). Here are some key points:

- Combination Therapy: Ocaliva is often given in combination with UDCA for adults who have not responded well enough to UDCA alone
- Monotherapy: O Show Full Answer

Yes, it is common for people with Primary Biliary Cholangitis (PBC) to be prescribed both Ursodeoxycholic Acid (UDCA) and Ocaliva (Obeticholic Acid). Here are some key points:

- Combination Therapy: Ocaliva is often given in combination with UDCA for adults who have not responded well enough to UDCA alone.
- Monotherapy: Ocaliva can also be used alone for adults who cannot tolerate UDCA.
- Mechanism: Ocaliva works by decreasing bile production and increasing bile removal from the liver.
- Side Effects: Common side effects of Ocaliva include itching, tiredness, stomach pain, rash, joint pain, mouth and throat pain, dizziness, constipation, swelling in hands or feet, fast or irregular heartbeat, fever, and changes in thyroid function. Rare but serious side effects include liver deterioration, potentially leading to liver failure.

Always follow your doctor's instructions and report any side effects you experience.

 This AI-generated response comes from myPBCteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Ocaliva (Obeticholic Acid) for PBC | myPBCteam

Primary Biliary Cholangitis Treatments and Their Side Effects | myPBCteam